Testosterone undecanoate is the ester prodrug of testosterone and has a midchain fatty acid at the 17Beta position.It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency.
Market Analysis and Insights: Global Testosterone Undecylate (TU) Market
The global Testosterone Undecylate (TU) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Testosterone Undecylate (TU) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Testosterone Undecylate (TU) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Testosterone Undecylate (TU) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Testosterone Undecylate (TU) market.
Testosterone Undecylate (TU) Breakdown Data by Type
Injection
Oral
Testosterone Undecylate (TU) Breakdown Data by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Based on regional and country-level analysis, the Testosterone Undecylate (TU) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Testosterone Undecylate (TU) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Organon
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Clarus Therapeutics
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine
Market Analysis and Insights: Global Testosterone Undecylate (TU) Market
The global Testosterone Undecylate (TU) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Testosterone Undecylate (TU) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Testosterone Undecylate (TU) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Testosterone Undecylate (TU) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Testosterone Undecylate (TU) market.
Testosterone Undecylate (TU) Breakdown Data by Type
Injection
Oral
Testosterone Undecylate (TU) Breakdown Data by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Based on regional and country-level analysis, the Testosterone Undecylate (TU) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Testosterone Undecylate (TU) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Organon
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Clarus Therapeutics
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Testosterone Undecylate (TU) Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Testosterone Undecylate (TU) Market Share by Application: 2020 VS 2026
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Testosterone Undecylate (TU) Market Perspective (2015-2026)
2.2 Global Testosterone Undecylate (TU) Growth Trends by Regions
2.2.1 Testosterone Undecylate (TU) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Testosterone Undecylate (TU) Historic Market Share by Regions (2015-2020)
2.2.3 Testosterone Undecylate (TU) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Testosterone Undecylate (TU) Players by Market Size
3.1.1 Global Top Testosterone Undecylate (TU) Players by Revenue (2015-2020)
3.1.2 Global Testosterone Undecylate (TU) Revenue Market Share by Players (2015-2020)
3.2 Global Testosterone Undecylate (TU) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Testosterone Undecylate (TU) Revenue
3.4 Global Testosterone Undecylate (TU) Market Concentration Ratio
3.4.1 Global Testosterone Undecylate (TU) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Testosterone Undecylate (TU) Revenue in 2019
3.5 Key Players Testosterone Undecylate (TU) Area Served
3.6 Key Players Testosterone Undecylate (TU) Product Solution and Service
3.7 Date of Enter into Testosterone Undecylate (TU) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Testosterone Undecylate (TU) Breakdown Data by Type (2015-2026)
4.1 Global Testosterone Undecylate (TU) Historic Market Size by Type (2015-2020)
4.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Type (2021-2026)
5 Testosterone Undecylate (TU) Breakdown Data by Application (2015-2026)
5.1 Global Testosterone Undecylate (TU) Historic Market Size by Application (2015-2020)
5.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Testosterone Undecylate (TU) Market Size (2015-2026)
6.2 North America Testosterone Undecylate (TU) Market Size by Type (2015-2020)
6.3 North America Testosterone Undecylate (TU) Market Size by Application (2015-2020)
6.4 North America Testosterone Undecylate (TU) Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Testosterone Undecylate (TU) Market Size (2015-2026)
7.2 Europe Testosterone Undecylate (TU) Market Size by Type (2015-2020)
7.3 Europe Testosterone Undecylate (TU) Market Size by Application (2015-2020)
7.4 Europe Testosterone Undecylate (TU) Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Testosterone Undecylate (TU) Market Size (2015-2026)
8.2 China Testosterone Undecylate (TU) Market Size by Type (2015-2020)
8.3 China Testosterone Undecylate (TU) Market Size by Application (2015-2020)
8.4 China Testosterone Undecylate (TU) Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Testosterone Undecylate (TU) Market Size (2015-2026)
9.2 Japan Testosterone Undecylate (TU) Market Size by Type (2015-2020)
9.3 Japan Testosterone Undecylate (TU) Market Size by Application (2015-2020)
9.4 Japan Testosterone Undecylate (TU) Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Testosterone Undecylate (TU) Market Size (2015-2026)
10.2 Southeast Asia Testosterone Undecylate (TU) Market Size by Type (2015-2020)
10.3 Southeast Asia Testosterone Undecylate (TU) Market Size by Application (2015-2020)
10.4 Southeast Asia Testosterone Undecylate (TU) Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Organon
11.1.1 Organon Company Details
11.1.2 Organon Business Overview
11.1.3 Organon Testosterone Undecylate (TU) Introduction
11.1.4 Organon Revenue in Testosterone Undecylate (TU) Business (2015-2020))
11.1.5 Organon Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Testosterone Undecylate (TU) Introduction
11.2.4 Bayer AG Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.2.5 Bayer AG Recent Development
11.3 Endo Pharmaceuticals
11.3.1 Endo Pharmaceuticals Company Details
11.3.2 Endo Pharmaceuticals Business Overview
11.3.3 Endo Pharmaceuticals Testosterone Undecylate (TU) Introduction
11.3.4 Endo Pharmaceuticals Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.3.5 Endo Pharmaceuticals Recent Development
11.4 Merck Sharp & Dohme
11.4.1 Merck Sharp & Dohme Company Details
11.4.2 Merck Sharp & Dohme Business Overview
11.4.3 Merck Sharp & Dohme Testosterone Undecylate (TU) Introduction
11.4.4 Merck Sharp & Dohme Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.4.5 Merck Sharp & Dohme Recent Development
11.5 Taro Pharmaceutical
11.5.1 Taro Pharmaceutical Company Details
11.5.2 Taro Pharmaceutical Business Overview
11.5.3 Taro Pharmaceutical Testosterone Undecylate (TU) Introduction
11.5.4 Taro Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.5.5 Taro Pharmaceutical Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Testosterone Undecylate (TU) Introduction
11.6.4 Cipla Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.6.5 Cipla Recent Development
11.7 Clarus Therapeutics
11.7.1 Clarus Therapeutics Company Details
11.7.2 Clarus Therapeutics Business Overview
11.7.3 Clarus Therapeutics Testosterone Undecylate (TU) Introduction
11.7.4 Clarus Therapeutics Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.7.5 Clarus Therapeutics Recent Development
11.8 Zhejiang Xianju Pharmaceutical
11.8.1 Zhejiang Xianju Pharmaceutical Company Details
11.8.2 Zhejiang Xianju Pharmaceutical Business Overview
11.8.3 Zhejiang Xianju Pharmaceutical Testosterone Undecylate (TU) Introduction
11.8.4 Zhejiang Xianju Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.8.5 Zhejiang Xianju Pharmaceutical Recent Development
11.9 Zhejiang Medicine
11.9.1 Zhejiang Medicine Company Details
11.9.2 Zhejiang Medicine Business Overview
11.9.3 Zhejiang Medicine Testosterone Undecylate (TU) Introduction
11.9.4 Zhejiang Medicine Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.9.5 Zhejiang Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Testosterone Undecylate (TU) Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Testosterone Undecylate (TU) Market Share by Application: 2020 VS 2026
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Testosterone Undecylate (TU) Market Perspective (2015-2026)
2.2 Global Testosterone Undecylate (TU) Growth Trends by Regions
2.2.1 Testosterone Undecylate (TU) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Testosterone Undecylate (TU) Historic Market Share by Regions (2015-2020)
2.2.3 Testosterone Undecylate (TU) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Testosterone Undecylate (TU) Players by Market Size
3.1.1 Global Top Testosterone Undecylate (TU) Players by Revenue (2015-2020)
3.1.2 Global Testosterone Undecylate (TU) Revenue Market Share by Players (2015-2020)
3.2 Global Testosterone Undecylate (TU) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Testosterone Undecylate (TU) Revenue
3.4 Global Testosterone Undecylate (TU) Market Concentration Ratio
3.4.1 Global Testosterone Undecylate (TU) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Testosterone Undecylate (TU) Revenue in 2019
3.5 Key Players Testosterone Undecylate (TU) Area Served
3.6 Key Players Testosterone Undecylate (TU) Product Solution and Service
3.7 Date of Enter into Testosterone Undecylate (TU) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Testosterone Undecylate (TU) Breakdown Data by Type (2015-2026)
4.1 Global Testosterone Undecylate (TU) Historic Market Size by Type (2015-2020)
4.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Type (2021-2026)
5 Testosterone Undecylate (TU) Breakdown Data by Application (2015-2026)
5.1 Global Testosterone Undecylate (TU) Historic Market Size by Application (2015-2020)
5.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Testosterone Undecylate (TU) Market Size (2015-2026)
6.2 North America Testosterone Undecylate (TU) Market Size by Type (2015-2020)
6.3 North America Testosterone Undecylate (TU) Market Size by Application (2015-2020)
6.4 North America Testosterone Undecylate (TU) Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Testosterone Undecylate (TU) Market Size (2015-2026)
7.2 Europe Testosterone Undecylate (TU) Market Size by Type (2015-2020)
7.3 Europe Testosterone Undecylate (TU) Market Size by Application (2015-2020)
7.4 Europe Testosterone Undecylate (TU) Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Testosterone Undecylate (TU) Market Size (2015-2026)
8.2 China Testosterone Undecylate (TU) Market Size by Type (2015-2020)
8.3 China Testosterone Undecylate (TU) Market Size by Application (2015-2020)
8.4 China Testosterone Undecylate (TU) Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Testosterone Undecylate (TU) Market Size (2015-2026)
9.2 Japan Testosterone Undecylate (TU) Market Size by Type (2015-2020)
9.3 Japan Testosterone Undecylate (TU) Market Size by Application (2015-2020)
9.4 Japan Testosterone Undecylate (TU) Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Testosterone Undecylate (TU) Market Size (2015-2026)
10.2 Southeast Asia Testosterone Undecylate (TU) Market Size by Type (2015-2020)
10.3 Southeast Asia Testosterone Undecylate (TU) Market Size by Application (2015-2020)
10.4 Southeast Asia Testosterone Undecylate (TU) Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Organon
11.1.1 Organon Company Details
11.1.2 Organon Business Overview
11.1.3 Organon Testosterone Undecylate (TU) Introduction
11.1.4 Organon Revenue in Testosterone Undecylate (TU) Business (2015-2020))
11.1.5 Organon Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Testosterone Undecylate (TU) Introduction
11.2.4 Bayer AG Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.2.5 Bayer AG Recent Development
11.3 Endo Pharmaceuticals
11.3.1 Endo Pharmaceuticals Company Details
11.3.2 Endo Pharmaceuticals Business Overview
11.3.3 Endo Pharmaceuticals Testosterone Undecylate (TU) Introduction
11.3.4 Endo Pharmaceuticals Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.3.5 Endo Pharmaceuticals Recent Development
11.4 Merck Sharp & Dohme
11.4.1 Merck Sharp & Dohme Company Details
11.4.2 Merck Sharp & Dohme Business Overview
11.4.3 Merck Sharp & Dohme Testosterone Undecylate (TU) Introduction
11.4.4 Merck Sharp & Dohme Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.4.5 Merck Sharp & Dohme Recent Development
11.5 Taro Pharmaceutical
11.5.1 Taro Pharmaceutical Company Details
11.5.2 Taro Pharmaceutical Business Overview
11.5.3 Taro Pharmaceutical Testosterone Undecylate (TU) Introduction
11.5.4 Taro Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.5.5 Taro Pharmaceutical Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Testosterone Undecylate (TU) Introduction
11.6.4 Cipla Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.6.5 Cipla Recent Development
11.7 Clarus Therapeutics
11.7.1 Clarus Therapeutics Company Details
11.7.2 Clarus Therapeutics Business Overview
11.7.3 Clarus Therapeutics Testosterone Undecylate (TU) Introduction
11.7.4 Clarus Therapeutics Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.7.5 Clarus Therapeutics Recent Development
11.8 Zhejiang Xianju Pharmaceutical
11.8.1 Zhejiang Xianju Pharmaceutical Company Details
11.8.2 Zhejiang Xianju Pharmaceutical Business Overview
11.8.3 Zhejiang Xianju Pharmaceutical Testosterone Undecylate (TU) Introduction
11.8.4 Zhejiang Xianju Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.8.5 Zhejiang Xianju Pharmaceutical Recent Development
11.9 Zhejiang Medicine
11.9.1 Zhejiang Medicine Company Details
11.9.2 Zhejiang Medicine Business Overview
11.9.3 Zhejiang Medicine Testosterone Undecylate (TU) Introduction
11.9.4 Zhejiang Medicine Revenue in Testosterone Undecylate (TU) Business (2015-2020)
11.9.5 Zhejiang Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
